Literature DB >> 16464446

A closer look at chemokines and their role in asthmatic responses.

Joost J Smit1, Nicholas W Lukacs.   

Abstract

Inflammatory cell recruitment is a hallmark phenomenon of all inflammatory diseases, including allergic asthma. In allergy and asthma, recruitment of inflammatory cells such as T cells, dendritic cells, mast cells, eosinophils and neutrophils, is mediated via a number of chemokines and their receptors. Not only are chemokines involved in recruitment of these cells, they also play a role in activation and differentiation of inflammatory cells, among others, by selectively activating Th1 or Th2 cells or by effects on epithelial or endothelial cells. Binding of chemokines with their receptors has been demonstrated to be highly promiscuous and the subsequent activation pattern on effector cells is very heterogeneous, which has lead to confusion and has complicated research in this field. Nonetheless, chemokines and their receptors are important potential therapeutical targets in allergy and asthma because of their central role in cell recruitment and activation during inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464446     DOI: 10.1016/j.ejphar.2005.12.064

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  35 in total

1.  IL-13 receptor α1 differentially regulates aeroallergen-induced lung responses.

Authors:  Marc E Rothenberg; Ting Wen; Dana Shik; Eric T Cole; Melissa M Mingler; Ariel Munitz
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

2.  Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice.

Authors:  Clement Oyeniran; Jamie L Sturgill; Nitai C Hait; Wei-Ching Huang; Dorit Avni; Michael Maceyka; Jason Newton; Jeremy C Allegood; Alison Montpetit; Daniel H Conrad; Sheldon Milstien; Sarah Spiegel
Journal:  J Allergy Clin Immunol       Date:  2015-04-02       Impact factor: 10.793

3.  Important role of neutrophils in the late asthmatic response in mice.

Authors:  Takeshi Nabe; Fusa Hosokawa; Kouki Matsuya; Toyoko Morishita; Ayumu Ikedo; Masanori Fujii; Nobuaki Mizutani; Shin Yoshino; David D Chaplin
Journal:  Life Sci       Date:  2011-04-30       Impact factor: 5.037

4.  Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma.

Authors:  A T Hastie; C Steele; C W Dunaway; W C Moore; B M Rector; E Ampleford; H Li; L C Denlinger; N Jarjour; D A Meyers; E R Bleecker
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

5.  Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages.

Authors:  Maya R Karta; Lisa E Wickert; Colleen S Curran; Monica L Gavala; Loren C Denlinger; James E Gern; Paul J Bertics
Journal:  J Allergy Clin Immunol       Date:  2014-02-14       Impact factor: 10.793

Review 6.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 7.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

8.  Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells.

Authors:  Atsushi Kato; Regina T Chustz; Takahisa Ogasawara; Marianna Kulka; Hirohisa Saito; Robert P Schleimer; Kenji Matsumoto
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.

Authors:  Justin Liu; Samuel Louie; Willy Hsu; Kristine M Yu; Hugh B Nicholas; Grace L Rosenquist
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

10.  CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.

Authors:  Younes J Errahali; Equar Taka; Barack O Abonyo; Ann S Heiman
Journal:  J Interferon Cytokine Res       Date:  2009-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.